Announced Mon, 3 Aug · 16:55 IST
MD and CEO Pankaj Jashwant Shah resigns effective August 3, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹115.80
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.9-5.8-7.7-9.5-11.3-12.3-25.3-16.2——
Up moveDown movePending
AI summary
Mr. Pankaj Jashwant Shah (DIN 02836324) has resigned as Managing Director and Chief Executive Director of Aspira Pathlab and Diagnostics with immediate effect from August 3, 2026, citing personal reasons. No replacement or interim arrangement has been announced in this filing. The communication was signed by Executive Director Nikunj Mange on behalf of the company. The exit leaves the top leadership post vacant pending a successor decision by the Board.
Likely market impact
Sudden exit of the top executive with no named successor may create short-term leadership uncertainty and could weigh on sentiment until a replacement is announced.